Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters

Markus Ketteler; Geoffrey A. Block; Pieter Evenepoel; Masafumi Fukagawa; Charles A. Herzog; Linda McCann; Sharon M. Moe; Rukshana Shroff; Marcello A. Tonelli; Nigel D. Toussaint; Marc G. Vervloet; Mary B. Leonard

doi:10.1016/j.kint.2017.04.006

Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters

Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel, Masafumi Fukagawa, Charles A. Herzog, Linda McCann, Sharon M. Moe, Rukshana Shroff, Marcello A. Tonelli, Nigel D. Toussaint, Marc G. Vervloet, Mary B. Leonard

Medicine - Cardiology Division

Research output: Contribution to journal › Article › peer-review

654 Scopus citations

Abstract

The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.

Original language	English (US)
Pages (from-to)	26-36
Number of pages	11
Journal	Kidney international
Volume	92
Issue number	1
DOIs	https://doi.org/10.1016/j.kint.2017.04.006
State	Published - Jul 2017

Bibliographical note

Publisher Copyright:
© 2017 KDIGO

Keywords

KDIGO CKD-MBD Guideline
bone mineral density
calcium
dialysis
hyperparathyroidism
hyperphosphatemia
kidney transplantation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.kint.2017.04.006

OpenUrl availability

Full text

Cite this

Ketteler, M., Block, G. A., Evenepoel, P., Fukagawa, M., Herzog, C. A., McCann, L., Moe, S. M., Shroff, R., Tonelli, M. A., Toussaint, N. D., Vervloet, M. G., & Leonard, M. B. (2017). Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney international, 92(1), 26-36. https://doi.org/10.1016/j.kint.2017.04.006

Ketteler, M, Block, GA, Evenepoel, P, Fukagawa, M, Herzog, CA, McCann, L, Moe, SM, Shroff, R, Tonelli, MA, Toussaint, ND, Vervloet, MG & Leonard, MB 2017, 'Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters', Kidney international, vol. 92, no. 1, pp. 26-36. https://doi.org/10.1016/j.kint.2017.04.006

@article{d79c55786588420db043a379b4b511f6,

title = "Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters",

abstract = "The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.",

keywords = "KDIGO CKD-MBD Guideline, bone mineral density, calcium, dialysis, hyperparathyroidism, hyperphosphatemia, kidney transplantation",

author = "Markus Ketteler and Block, {Geoffrey A.} and Pieter Evenepoel and Masafumi Fukagawa and Herzog, {Charles A.} and Linda McCann and Moe, {Sharon M.} and Rukshana Shroff and Tonelli, {Marcello A.} and Toussaint, {Nigel D.} and Vervloet, {Marc G.} and Leonard, {Mary B.}",

note = "Publisher Copyright: {\textcopyright} 2017 KDIGO",

year = "2017",

month = jul,

doi = "10.1016/j.kint.2017.04.006",

language = "English (US)",

volume = "92",

pages = "26--36",

journal = "Kidney international",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update

T2 - what's changed and why it matters

AU - Ketteler, Markus

AU - Block, Geoffrey A.

AU - Evenepoel, Pieter

AU - Fukagawa, Masafumi

AU - Herzog, Charles A.

AU - McCann, Linda

AU - Moe, Sharon M.

AU - Shroff, Rukshana

AU - Tonelli, Marcello A.

AU - Toussaint, Nigel D.

AU - Vervloet, Marc G.

AU - Leonard, Mary B.

PY - 2017/7

Y1 - 2017/7

N2 - The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.

AB - The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.

KW - KDIGO CKD-MBD Guideline

KW - bone mineral density

KW - calcium

KW - dialysis

KW - hyperparathyroidism

KW - hyperphosphatemia

KW - kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=85021339948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021339948&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2017.04.006

DO - 10.1016/j.kint.2017.04.006

M3 - Article

C2 - 28646995

AN - SCOPUS:85021339948

SN - 0085-2538

VL - 92

SP - 26

EP - 36

JO - Kidney international

JF - Kidney international

IS - 1

ER -